drugset / Trial / NCT00681915

AZD7325 Multiple Ascending Dose Study

NCT00681915

Phase 1 Completed 48 enrolled AstraZeneca
RandomizedSingle-groupQuadruple-blindTreatment

Summary

This is a study to evaluate safety, tolerability, PK and PD effects of orally administered AZD7325 after single and repeated ascending doses.

Timeline

Start
2008-03
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7325 Small molecule Oral

Indications

No indication recorded.